Hollis Brownstein Research Grants Program

The Leukemia Research Foundation exclusively funds New Investigators - individuals beginning to establish their own laboratories that are no longer under the tutelage of a senior scientist mentor. It is difficult for them to get the level of funding they need at this critical point in their careers.

The Leukemia Research Foundation is unique in the level of support it provides to highly promising scientists in this absolutely critical research niche. Providing one year grants of $100,000 to selected New Investigator researchers, allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. The Leukemia Research Foundation funds the research of scientists that are from independent labs, not the labs of pharmaceutical companies.

Researchers funded by the LRF publish their results in an effort to inform the scientific community about their advances. In addition, their initial results are used to obtain grants from larger, multi-year funding sources - thus furthering their research and potential for finding a cure.

Support of the LRF will fuel today’s creative ideas and help launch the careers of scientists who may further our understanding of blood cancers for years to come. Founded in 1946, the LRF has raised more than $80 million in its 73-year history supporting its mission.

How are these research grants distributed?

Expert recommendations on who receives the grants are made by the Leukemia Research Foundation’s Medical Advisory Board, an independent volunteer board comprised of prominent and qualified M.D.s and Ph.D.s with expertise in leukemia, lymphoma, multiple myeloma, and myleodysplastic syndromes.

The Board convenes each year to discuss and prioritize the grant applications from scientists around the world. The criterion on which the panel bases their assessment includes three basic points:

Innovation – the innovation a proposal offers, discerning whether the findings will contribute to leukemia, lymphoma, multiple myeloma, and MDS research.

Mission – what effect the study may have on how blood cancers are detected, diagnosed and treated.

Training/Environment – training and preparedness of the applicant & their research setting.

"Funding New Investigators is extremely important because this is the beginning of a talented individual’s career, and it’s also a time when they’re most vulnerable. They don’t have much of a track record except their college records and their graduate school records, so major organizations and the national government don’t fund very many of them."


Janet Rowley, M.D.
Leukemia Research Foundation research grant recipient, National Medal of Science recipient, 2009 Presidential Medal of Freedom Recipient.